Similar articles for PMID: 33361183

Year	Number of Results
2000	1
2001	1
2002	1
2003	3
2004	3
2005	2
2006	2
2007	3
2008	7
2009	3
2010	4
2011	7
2012	5
2013	5
2014	12
2015	11
2016	9
2017	11
2018	7
2019	9
2020	6
2021	5
2022	1
2023	1
2024	0

1

Pitfalls and Artifacts of ¹²³I-Ioflupane SPECT in Parkinsonian Syndromes: A Quality Improvement Teaching Tool.

Tuma Santos CA, Wallace WD, Kim S, Vijayakumar V. Tuma Santos CA, et al. J Nucl Med Technol. 2021 Jun;49(2):114-119. doi: 10.2967/jnmt.120.258491. Epub 2020 Dec 24. J Nucl Med Technol. 2021. PMID: 33361183 Free article. Review.

2

Optimizing the Diagnosis of Parkinsonian Syndromes With ¹²³I-Ioflupane Brain SPECT.

Banks KP, Peacock JG, Clemenshaw MN, Kuo PH. Banks KP, et al. AJR Am J Roentgenol. 2019 Aug;213(2):243-253. doi: 10.2214/AJR.19.21088. Epub 2019 Apr 17. AJR Am J Roentgenol. 2019. PMID: 30995085 Review.

3

Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes.

Bairactaris C, Demakopoulos N, Tripsianis G, Sioka C, Farmakiotis D, Vadikolias K, Heliopoulos I, Georgoulias P, Tsougos I, Papanastasiou I, Piperidou C. Bairactaris C, et al. J Clin Neurosci. 2009 Feb;16(2):246-52. doi: 10.1016/j.jocn.2008.01.020. Epub 2008 Dec 20. J Clin Neurosci. 2009. PMID: 19097795

4

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.

Bajaj N, Hauser RA, Grachev ID. Bajaj N, et al. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1288-95. doi: 10.1136/jnnp-2012-304436. Epub 2013 Mar 13. J Neurol Neurosurg Psychiatry. 2013. PMID: 23486993 Free PMC article. Review.

5

Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.

Badoud S, Van De Ville D, Nicastro N, Garibotto V, Burkhard PR, Haller S. Badoud S, et al. Neuroimage Clin. 2016 Jul 5;12:234-40. doi: 10.1016/j.nicl.2016.07.004. eCollection 2016. Neuroimage Clin. 2016. PMID: 27489771 Free PMC article.

6

CT-based attenuation correction in I-123-ioflupane SPECT.

Lange C, Seese A, Schwarzenböck S, Steinhoff K, Umland-Seidler B, Krause BJ, Brenner W, Sabri O, Kurth J, Hesse S, Buchert R. Lange C, et al. PLoS One. 2014 Sep 30;9(9):e108328. doi: 10.1371/journal.pone.0108328. eCollection 2014. PLoS One. 2014. PMID: 25268228 Free PMC article.

7

Atypical Parkinsonian syndromes with very poor striatal uptake on 123I-ioflupane SPECT imaging.

Dibble EH, Yoo DC, Noto RB, Friedman JH. Dibble EH, et al. Clin Nucl Med. 2015 Feb;40(2):e152-6. doi: 10.1097/RLU.0000000000000608. Clin Nucl Med. 2015. PMID: 25546212

8

Pearls and Pitfalls of Quantitative Software Analysis of Dopamine Transporter SPECT.

Mushtaq R, Kay MD, Steinmeyer L, Warhadpande D, Kuo PH. Mushtaq R, et al. Clin Nucl Med. 2020 Nov;45(11):e469-e476. doi: 10.1097/RLU.0000000000003183. Clin Nucl Med. 2020. PMID: 32701796

9

Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.

Petyt G, Kreisler A, Demailly F, Olivier A, Defebvre L, Semah F. Petyt G, et al. J Neurol Sci. 2014 Jun 15;341(1-2):167-71. doi: 10.1016/j.jns.2014.04.024. Epub 2014 Apr 30. J Neurol Sci. 2014. PMID: 24814162

10

Diagnostic Performance of the Visual Reading of ¹²³I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia.

Booij J, Dubroff J, Pryma D, Yu J, Agarwal R, Lakhani P, Kuo PH. Booij J, et al. J Nucl Med. 2017 Nov;58(11):1821-1826. doi: 10.2967/jnumed.116.189266. Epub 2017 May 4. J Nucl Med. 2017. PMID: 28473597 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

103 results

Results by year